About

About us

WMG Vertical Logo - 494X144px

WellTree Molecular Group assists in the direct sales, distribution, and international business development for revolutionary invitro diagnostics testing solutions.

Our Story

WellTree Molecular Group is founded by health care operation professionals. Our commitment to excellence and innovation is the guiding philosophy of the team. Our operational expertise has served small and large hospital groups, retail pharmacy, and point-of-care businesses across all patient populations and throughout the U.S.

As the COVID-19 pandemic forced the world into turmoil, the WellTree team adopted the challenge to address the bottleneck of tools and education needed in the war chest to fight against infectious disease. WellTree continually evaluates solutions and products needed to actively fight the pandemic and reopen the country.


Incorporated - 2019

Sales Team - 50

Corporate Team - 8

Renée Marchand

Renée Marchand

Pharm.D. & COO
Pharm.D. & COO Renee works closely with emerging medical device innovators and manufacturers to find a space in the marketplace for the value they bring to doctors, patients, and communities. Renee has 10 plus years of experience in the field both as a pharmacist and business manager.
Christen Wall

Christen Wall

Chief Revenue Officer (CRO)
Chief Revenue Officer (CRO) Christen’s experience in sales and entrepreneurship is grounded in core US industries. Christen is charged with building a national and international sales team with distributor partnerships. Her goal is to educate and inform about novel devices savings and efficiencies in the point-of-care practice.
Ann Flamm

Ann Flamm

B.A., CPhT – Compliance Manager
B.A., CPhT – Compliance Manager Ann’s years of experience in Pharmacy has established her with knowledge on Federal and State compliance requirements for Healthcare and has maintained great relationships with regulatory representatives. Ann is charged with maintaining complete and accurate tracking records for all medical device sales.
Szilard Voros

Szilard Voros

External Scientific Advisor
External Scientific Advisor Dr. Voros is the Founder and CEO of Global Genomics Group (“G3”), a precision-medicine-based biotechnology company, developing and commercializing diagnostic biomarkers and novel drug targets for common diseases. G3’s platform is based on the largest-ever program using DNA and RNA sequencing, proteomics, metabolomics, lipidomic and other platforms. He has published extensively in Nature Reviews, New England Journal of Medicine and Annals of Internal Medicine.

Apply for a Job!

We are always looking for quality talent to be a part of the WellTree team. Go to our Careers page for information on current available positions.